Application for quotation of securities - PAR
Released
Released
Announcement PDF
Appendix 2A - Application for quotation of securities
Announcement Summary
Entity name
PARADIGM BIOPHARMACEUTICALS LIMITED..
Announcement Type
New announcement
Date of this announcement
Tuesday February 11, 2025
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Total number of +securities to be quoted
ASX +security
code
Security description
PAROA
OPTION EXPIRING 11-FEB-2026 DEFERRED
Number of +securities to
be quoted
Issue date
97,360,143
11/02/2025
Refer to next page for full details of the announcement
Appendix 2A - Application for quotation of securities
1/6
Appendix 2A - Application for quotation of securities
Part 1 - Entity and announcement details
1.1 Name of entity
PARADIGM BIOPHARMACEUTICALS LIMITED..
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix
2A of the ASX Listing Rules.
1.2 Registered number type
Registration number
ACN
169346963
1.3 ASX issuer code
PAR
1.4 The announcement is
New announcement
1.5 Date of this announcement
11/2/2025
Appendix 2A - Application for quotation of securities
2/6
Appendix 2A - Application for quotation of securities
Part 2 - Type of Issue
2.1 The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Previous Appendix 3B details:
Announcement Date and
Time
Announcement Title
Selected Appendix 3B to submit quotation
request
03-Feb-2025 08:28
New - Proposed issue of securities PAR
A +bonus issue
2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the
Appendix 3B?
No
Appendix 2A - Application for quotation of securities
3/6
Appendix 2A - Application for quotation of securities
Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
Corporate Action Component Detail
ASX +security code and description
PAROA : OPTION EXPIRING 11-FEB-2026 DEFERRED
Issue date
11/2/2025
Distribution Schedule
Provide a distribution schedule for the new +securities according to the categories set out in the left hand column including the number of recipients and the total percentage of the new +securities held by the recipients in each
category.
Number of +securities held
Total percentage of +securities held
For example, to enter a value of 50%
please input as 50.00
Number of holders
1 - 1,000
%
1,001 - 5,000
%
5,001 - 10,000
%
10,001 - 100,000
%
100,001 and over
%
Issue details
Number of +securities to be quoted
97,360,143
Issue currency
Issue price or consideration per +security
AUD - Australian Dollar
AUD 0.00000000
Any other information the entity wishes to provide about the +securities to be quoted
Appendix 2A - Application for quotation of securities
4/6
Appendix 2A - Application for quotation of securities
Appendix 2A - Application for quotation of securities
5/6
Appendix 2A - Application for quotation of securities
Part 4 - Issued capital following quotation
Following the quotation of the +securities the subject of this application, the issued capital of the entity will
comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if
other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the
+securities subject of this application)
ASX +security code and description
Total number of
+securities on issue
PAR : ORDINARY FULLY PAID
389,428,603
PAROA : OPTION EXPIRING 11-FEB-2026 DEFERRED
97,360,143
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description
Total number of
+securities on issue
PARAAB : OPTION EXPIRING 09-FEB-2026 EX $0.65
2,500,000
PARAAC : PERFORMANCE RIGHTS
6,558,600
Appendix 2A - Application for quotation of securities
6/6
Share your feedback
Discover